Today’s “hot news story” in the cancer world is that a very widely used drug called warfarin (often still known as Coumadin) may be able to protect people from the risks of getting diagnosed with at least some cancers. But … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: anticoagulant, Coumadin, Prevention, risk, warfarin | 2 Comments »
There is an interesting new paper in Cancer Biology and Therapy again suggesting the possibility that men diagnosed with high-risk prostate cancer who are taking anticoagulant therapy do better than similar men who are not on anticoagulants. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: "high risk", anticoagulant, outcome, radiation | 5 Comments »
At the Genitourinary Cancers Symposium a week ago there was a poster on a potential association between the use of blood thinners (i.e., the anticoagulants warfarin and low molecular weight heparin) by men with metastatic, castration-resistant prostate cancer (mCRPC) who had received docetaxel-based chemotherapy and an increase in overall survival benefit. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: anticoagulant | 1 Comment »
A study based on the CaPSURE database, and just published in the Journal of Oncology, has again suggested that prostate cancer patients who are regular users of anticoagulant are a lower risk of prostate cancer-specific mortality than non-aspirin users. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: anticoagulant, aspirin, cancer-specific, mortality | Leave a comment »
In today’s news reports we comment briefly on recent papers that deal with:
Filed under: Living with Prostate Cancer, Management, Risk, Treatment | Tagged: anticoagulant, chemotherapy, elderly, LRP, outcome, pre-surgical, radiation therapy, radical prostatectomy | 1 Comment »
Data presented last Monday at the annual meeting of the American Society for Radiation Oncology (ASTRO) suggest a possible role of anticoagulant therapy (using drugs like aspirin, warfarin, or clopidogrel/Plavix) in combination with radiation for the treatment of localized prostate cancer. … READ MORE …
Filed under: Management, Treatment | Tagged: anticoagulant, aspirin, clopidogrel, radiation, warfarin | Leave a comment »
A recent study has assessed the risk of bleeding as a consequence of radiation therapy for localized prostate cancer in men being treated with anticoagulants . … READ MORE …
Filed under: Management, Treatment | Tagged: anticoagulant, bleeding, clopidogrel, EBRT, external beam radiation, risk, warfarin | 2 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 